• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma.

作者信息

Orouji A, Goerdt S, Utikal J, Leverkus M

机构信息

Department of Dermatology, Venereology and Allergology, University Medical Center, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany; Ruprecht-Karl-University of Heidelberg, Mannheim, Germany.

出版信息

Br J Dermatol. 2014 Aug;171(2):431-3. doi: 10.1111/bjd.12840. Epub 2014 Aug 2.

DOI:10.1111/bjd.12840
PMID:24446722
Abstract
摘要

相似文献

1
Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma.在使用维莫德吉治疗无法手术的基底细胞癌期间出现的多个高分化和中分化皮肤鳞状细胞癌。
Br J Dermatol. 2014 Aug;171(2):431-3. doi: 10.1111/bjd.12840. Epub 2014 Aug 2.
2
Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib.在用维莫德吉治疗过程中，鳞状细胞癌发展为基底细胞癌。
J Eur Acad Dermatol Venereol. 2015 May;29(5):1006-9. doi: 10.1111/jdv.12526. Epub 2014 Jul 1.
3
Vismodegib granted FDA approval for treatment of basal cell carcinoma.维莫德吉获美国食品药品监督管理局批准用于治疗基底细胞癌。
Oncology (Williston Park). 2012 Feb;26(2):174, 213.
4
Vismodegib (Erivedge) for basal cell carcinoma.维莫德吉（Erivedge）用于治疗基底细胞癌。
Med Lett Drugs Ther. 2012 Jul 9;54(1394):53-4.
5
Four-year experience with vismodegib hedgehog inhibitor therapy.维莫德吉（vismodegib）刺猬因子抑制剂治疗的四年经验
J Am Acad Dermatol. 2016 Jun;74(6):1264-5. doi: 10.1016/j.jaad.2015.12.035.
6
Vismodegib for periocular and orbital basal cell carcinoma.维莫德吉治疗眼周和眼眶基底细胞癌。
JAMA Ophthalmol. 2013 Dec;131(12):1591-4. doi: 10.1001/jamaophthalmol.2013.5018.
7
Vismodegib in the treatment of advanced BCC.维莫德吉用于治疗晚期基底细胞癌。
Ir Med J. 2014 Jul-Aug;107(7):215-6.
8
Reversible cutaneous side effects of vismodegib treatment.维莫德吉治疗的可逆性皮肤副作用。
Cutis. 2017 Mar;99(3):E19-E20.
9
Vismodegib (ERIVEDGE°) In basal cell carcinoma: too many unknowns.维莫德吉（ERIVEDGE°）用于基底细胞癌：未知因素过多。
Prescrire Int. 2015 Jan;24(156):11-4.
10
Vismodegib in basal cell carcinoma.维莫德吉治疗基底细胞癌
Drugs Today (Barc). 2012 Jul;48(7):459-67. doi: 10.1358/dot.2012.48.7.1808490.

引用本文的文献

1
Secondary cutaneous malignancy after treatment of basal cell carcinoma with hedgehog pathway inhibitor: a systematic review.治疗基底细胞癌的 Hedgehog 通路抑制剂后继发皮肤第二恶性肿瘤：系统评价。
Arch Dermatol Res. 2024 Oct 26;316(10):716. doi: 10.1007/s00403-024-03471-6.
2
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies.评估 Hedgehog 通路抑制剂治疗晚期基底细胞癌的耐受性：治疗策略的叙述性综述。
Am J Clin Dermatol. 2024 Sep;25(5):779-794. doi: 10.1007/s40257-024-00870-3. Epub 2024 Jun 19.
3
Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma.
在维莫德吉治疗基底细胞癌期间发生的转移性同部位鳞状细胞癌。
JAAD Case Rep. 2022 Aug 10;28:54-57. doi: 10.1016/j.jdcr.2022.07.032. eCollection 2022 Oct.
4
Spreading of Isolated Mutant Basal Cell Carcinoma Precursors Is Physiologically Suppressed and Counteracts Tumor Formation in Mice.孤立突变基底细胞癌前体的扩散在生理上受到抑制，并在小鼠中对抗肿瘤形成。
Int J Mol Sci. 2020 Dec 5;21(23):9295. doi: 10.3390/ijms21239295.
5
Genetic and environmental factors underlying keratinocyte carcinoma risk.导致角质形成细胞癌风险的遗传和环境因素。
JCI Insight. 2020 May 21;5(10):134783. doi: 10.1172/jci.insight.134783.
6
Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.基底鳞状细胞癌表型可塑性的遗传突变。
J Invest Dermatol. 2019 Nov;139(11):2263-2271.e5. doi: 10.1016/j.jid.2019.03.1163. Epub 2019 Jun 15.
7
New developments in the treatment of basal cell carcinoma: update on current and emerging treatment options with a focus on vismodegib.基底细胞癌治疗的新进展：聚焦维莫德吉的当前及新兴治疗选择的最新情况
Onco Targets Ther. 2018 Nov 23;11:8327-8340. doi: 10.2147/OTT.S135650. eCollection 2018.
8
YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.YAP-TEAD 信号通过 c-JUN/AP1 轴促进基底细胞癌的发展。
EMBO J. 2018 Sep 3;37(17). doi: 10.15252/embj.201798642. Epub 2018 Jul 23.
9
Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer.靶向表皮生长因子受体的嵌合单克隆抗体西妥昔单抗治疗晚期非黑色素瘤皮肤癌
Open Access Maced J Med Sci. 2017 Dec 31;6(1):152-155. doi: 10.3889/oamjms.2018.022. eCollection 2018 Jan 25.
10
Aggressive basal cell carcinoma of the head and neck: challenges in surgical management.头颈部侵袭性基底细胞癌：手术治疗面临的挑战
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3881-3889. doi: 10.1007/s00405-016-4039-9. Epub 2016 Apr 11.